EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,872,000 | -44.8% | 119,394 | -20.2% | 0.03% | -51.5% |
Q1 2022 | $3,392,000 | +81.0% | 149,637 | +46.0% | 0.07% | +34.7% |
Q4 2021 | $1,874,000 | -17.7% | 102,523 | -4.9% | 0.05% | +16.7% |
Q3 2021 | $2,278,000 | +23.9% | 107,779 | +6.8% | 0.04% | +23.5% |
Q2 2021 | $1,838,000 | -64.6% | 100,884 | -56.2% | 0.03% | -61.8% |
Q1 2021 | $5,198,000 | +279.4% | 230,091 | +237.1% | 0.09% | +256.0% |
Q4 2020 | $1,370,000 | +439.4% | 68,266 | +538.0% | 0.02% | +108.3% |
Q2 2020 | $254,000 | – | 10,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |